medicationPrescription only (US)FDA-approved prescription anticoagulant (brand name Coumadin, among others) for conditions including atrial fibrillation, venous thromboembolism, and antiphospholipid syndromeRequires routine INR monitoring and carries a boxed warning for bleeding risk
Warfarin (Coumadin)Benefits, Dosage & Interactions
Also known as: Coumadin
Warfarin, commonly known by its brand name Coumadin, is an anticoagulant medication. It functions as a vitamin K antagonist, meaning it reduces the ability of blood to clot. It is typically taken evening. The reported plasma half-life is about 20 hours, which shapes dosing frequency.
Researched by DoseRoutine R&D TeamReviewed for accuracy by Nicholas Alexander, RSELast updated
Evidence: Strong — 3 human randomized trials and regulatory approval on file.
Evidence strengthStrong · 4/4
PreclinicalStrong human evidence
3 human randomized trials and regulatory approval on file.
Plasma half-life
20–60 h
Typical timing
evening
Default unit
mg
What published protocols report
Ranges documented in the literature, shown for reference. DoseRoutine does not recommend an amount — your prescriber or the product label sets the dose.
- Reported amounts
- Warfarin arms in these trials used individualized dosing titrated to a target INR (generally 2.0–3.0 for atrial fibrillation, higher for antiphospholipid syndrome), rather than a fixed dose, because of its narrow therapeutic index and wide interpatient variability[1][2][3]
Reported for Warfarin (Coumadin) in the cited sources. Published ranges are not dosing advice.
References & evidence
Documents the Warfarin (Coumadin) entry is written from. Each number matches an inline marker above.
- [1]Rivaroxaban versus warfarin in nonvalvular atrial fibrillationPatel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W · The New England Journal of Medicine · 2011 · Peer-reviewed · PMID 21830957
- [2]Apixaban compared with warfarin to prevent thrombosis in thrombotic antiphospholipid syndrome: a randomized trialWoller SC, Stevens SM, Kaplan D, Wang TF, Branch DW, Groat D · Blood Advances · 2022 · Peer-reviewed · PMID 34662890
- [3]Reversal of asymptomatic over-anticoagulation by orally administered vitamin KBaker P, Gleghorn A, Tripp T, Paddon K, Eagleton H, Keeling D · British Journal of Haematology · 2006 · Peer-reviewed · PMID 16643436
How to track Warfarin (Coumadin) doses
Tracking Warfarin (Coumadin) well takes four fields and a habit. Here is what to record so the log is still useful in three months.
- 1
Add the dose and unit
Log Warfarin (Coumadin) with its dose in mg so totals stay comparable over time — including days when you split the dose or skip it.
- 2
Set the time of day and food rule
Typical timing is evening. Reminders fire at that time and can export to your calendar.
- 3
Check it against the rest of the stack
Run Warfarin (Coumadin) through the interaction checker against everything else in the routine — supplements, peptides, hormones and prescriptions — before it becomes a daily habit.
- 4
Log adherence, not intentions
Mark each dose taken, skipped or delayed as it happens. Weeks of honest logs are what make an adherence rate or a trend line meaningful; retrospective guessing is not.
- 5
Review against outcomes
With a reported half-life around 20 h, effects and timing shifts show up over days rather than instantly. Review Warfarin (Coumadin) alongside your logged metrics and any relevant blood work every few weeks before changing the dose.
What to log each time
- Dose in mg
- Time of day
- Taken / skipped / delayed
- Any side effects or notable changes
References & Evidence
Sources on this page that document Warfarin (Coumadin) dosing, timing and safety.
- [1]National Center for Biotechnology Information View source
Educational information only — not medical advice. Dose ranges vary by person, indication and prescriber.
What is Warfarin (Coumadin)?Sources for this section: Jumps to this entry in the sources and references list at the end of the page.
Warfarin, commonly known by its brand name Coumadin, is an anticoagulant medication. It functions as a vitamin K antagonist, meaning it reduces the ability of blood to clot. This effect is beneficial in preventing and treating various conditions where blood clots can be dangerous, such as deep vein thrombosis (DVT), pulmonary embolism (PE), and stroke in individuals with certain heart conditions like atrial fibrillation or prosthetic heart valves. Warfarin is an oral medication that requires careful monitoring by healthcare professionals due to its narrow therapeutic index and significant potential for interactions with other medications and foods. (Mayo Clinic, MedlinePlus)
What does the research say about Warfarin (Coumadin)?
Tap a section to expand.
Warfarin exerts its anticoagulant effect by interfering with the body's vitamin K recycling pathway. Specifically, it inhibits the enzyme vitamin K epoxide reductase (VKORC1). This enzyme is crucial for regenerating reduced vitamin K, which is a cofactor required for the gamma-carboxylation of specific proteins in the liver. These vitamin K-dependent clotting factors include factors II (prothrombin), VII, IX, and X, as well as protein C and protein S. By inhibiting VKORC1, warfarin depletes functional vitamin K locally available to the liver, leading to the production of under-carboxylated (and thus less active or inactive) clotting factors. The delayed onset of action, typically 2-7 days, is due to the time required for the existing functional clotting factors to be cleared from the circulation. (DrugBank, FDA label)
Source for this section: Sources for How does Warfarin (Coumadin) work?: Jumps to this entry in the sources and references list at the end of the page.
Warfarin is primarily used to prevent and treat thromboembolic events. Its main benefits include:
* **Prevention of stroke in atrial fibrillation:** Atrial fibrillation is an irregular heart rhythm that can lead to the formation of blood clots in the heart, which can then travel to the brain and cause a stroke. Warfarin significantly reduces this risk. (Mayo Clinic, NIH)
* **Treatment and prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE):** DVT involves blood clot formation in a deep vein, often in the legs, while PE occurs when a part of a DVT breaks off and travels to the lungs. Warfarin is effective in treating these conditions and preventing their recurrence. (MedlinePlus)
* **Prevention of clotting in individuals with prosthetic heart valves:** Mechanical heart valves increase the risk of blood clot formation. Warfarin helps prevent these clots, which could otherwise lead to valve dysfunction or stroke. (American Heart Association)
* **Prevention of clotting after certain surgical procedures:** In some cases, warfarin may be used to prevent blood clots after major surgeries, particularly orthopedic procedures. (Cochrane Review)
Numerous clinical trials and systematic reviews have established the efficacy of warfarin in preventing and treating various thromboembolic conditions. For instance, studies in patients with atrial fibrillation have consistently shown that warfarin reduces the risk of ischemic stroke by approximately two-thirds compared to placebo. (Cochrane Review) Similarly, its effectiveness in preventing recurrent DVT and PE is well-documented, with studies demonstrating significant reductions in recurrence rates compared to no anticoagulation. Evidence from large observational studies and randomized controlled trials supports its use for preventing thromboembolic complications in patients with mechanical heart valves. The therapeutic benefits of warfarin are weighed against its bleeding risks, which are carefully managed through regular international normalized ratio (INR) monitoring. (NIH National Heart, Lung, and Blood Institute)
The most common and serious side effect of warfarin is bleeding. This can range from minor bleeding, such as nosebleeds or bruising, to severe and life-threatening hemorrhages, including gastrointestinal bleeding, intracranial hemorrhage (bleeding in the brain), or bleeding into other organs. Other potential side effects include:
* Nausea, vomiting, diarrhea
* Abdominal pain
* Bloating
* Liver enzyme elevations
* Skin necrosis (rare, but serious, typically occurring early in treatment)
* Purple toe syndrome (rare vascular complication)
* Allergic reactions (rash, itching)
Regular monitoring of blood clotting levels (INR) is crucial to manage the risk of bleeding. If unusual bleeding or severe side effects occur, medical attention should be sought immediately. This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
Warfarin carries a boxed warning from the U.S. Food and Drug Administration (FDA) regarding its potential to cause major or fatal bleeding. Regular monitoring of the international normalized ratio (INR) is essential to guide dosing and assess the risk of bleeding. Individuals must be educated on the importance of adherence, dietary considerations (especially vitamin K intake), and drug interactions. Patients with a history of bleeding disorders, uncontrolled high blood pressure, recent surgery (especially brain, spinal, or eye surgery), or certain medical conditions (e.g., peptic ulcer disease) are at increased risk. The effects of warfarin can be reversed with vitamin K or clotting factor concentrates in emergency situations. Patients should carry identification indicating they are taking warfarin. This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
Warfarin is contraindicated in individuals with certain conditions due to an unacceptably high risk of bleeding. These contraindications include:
* Pregnancy (especially during the first trimester and near term, due to fetal bleeding risk and teratogenicity).
* Hemorrhagic tendencies or blood dyscrasias.
* Recent or impending surgery (especially neurosurgical, ophthalmic, or major abdominal surgery).
* Active pathological bleeding (e.g., active ulceration, intracranial hemorrhage).
* Severe uncontrolled hypertension.
* Bacterial endocarditis.
* Pericarditis or pericardial effusion.
* Lumbar puncture or other diagnostic or therapeutic procedures with potential for uncontrolled bleeding.
* Known hypersensitivity to warfarin. (FDA label, MedlinePlus) This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
Warfarin has numerous drug, food, and herbal interactions that can significantly alter its anticoagulant effect, leading to either increased bleeding risk or reduced effectiveness.
* **Drugs that increase warfarin's effect (increased bleeding risk):** Nonsteroidal anti-inflammatory drugs (NSAIDs), aspirin, certain antibiotics (e.g., metronidazole, trimethoprim-sulfamethoxazole), antifungals (e.g., fluconazole), amiodarone, cimetidine, and some antidepressants (SSRIs).
* **Drugs that decrease warfarin's effect (increased clotting risk):** Barbiturates, carbamazepine, rifampin, and certain HIV medications.
* **Herbal supplements:** High doses of vitamin E, ginkgo biloba, garlic, dong quai, and highly concentrated fish oil supplements may increase bleeding risk. St. John's wort can decrease warfarin's effectiveness.
* **Foods:** Foods rich in vitamin K (e.g., leafy green vegetables like spinach, kale, broccoli) can reduce warfarin's effectiveness. Consistency in vitamin K intake is more important than strict avoidance. Cranberry products, grapefruit juice, and alcohol can also interact.
It is crucial to inform all healthcare providers, including pharmacists, about all medications, supplements, and herbal products being taken to avoid dangerous interactions. This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
Warfarin is typically administered once daily in the evening. The consistent timing of administration helps to maintain stable drug levels and facilitate regular monitoring of its effects through INR tests. While warfarin can be taken with or without food, maintaining consistency regarding meal timing relative to medication intake is often advised to prevent potential fluctuations in absorption. The dose is user-directed and must be set by a licensed clinician. Consistency in administration time and relation to meals helps clinicians interpret INR results more accurately. (FDA label, DrugBank)
Source for this section: Sources for When should you take Warfarin (Coumadin)?: Jumps to this entry in the sources and references list at the end of the page.
What interacts with Warfarin (Coumadin)?
| Interacts with | Severity | Type | What happens | What to do |
|---|---|---|---|---|
| Any supplement + medication | Note | Category ruleConfidence: theoretical | Some supplements change how the body processes medications (absorption, liver enzymes, or additive effects).Source pending | Specific pairs are checked against a licensed drug database and shown with their own severity. Always confirm with your provider or pharmacist. |
| Any vitamin + medication | Note | Category ruleConfidence: theoretical | Certain vitamins interact with specific medications (e.g., vitamin K with blood thinners).Source pending | Specific pairs are checked against a licensed source; confirm with your provider. |
| Omega-3 (Fish Oil) | Caution | Compound pairConfidence: theoretical | Additive antiplatelet/antithrombotic effect increases bleeding risk.Source pending | Discuss with prescribing clinician; monitor for bruising, prolonged bleeding, and dose adjustments. |
| Fish Oil (High EPA) | Caution | Compound pairConfidence: theoretical | Additive antiplatelet/antithrombotic effect increases bleeding risk.Source pending | Discuss with prescribing clinician; monitor for bruising, prolonged bleeding, and dose adjustments. |
| Krill Oil | Caution | Compound pairConfidence: theoretical | Additive antiplatelet/antithrombotic effect increases bleeding risk.Source pending | Discuss with prescribing clinician; monitor for bruising, prolonged bleeding, and dose adjustments. |
| Curcumin | Caution | Compound pairConfidence: theoretical | Additive antiplatelet/antithrombotic effect increases bleeding risk.Source pending | Discuss with prescribing clinician; monitor for bruising, prolonged bleeding, and dose adjustments. |
| Vitamin E | Caution | Compound pairConfidence: theoretical | Additive antiplatelet/antithrombotic effect increases bleeding risk.Source pending | Discuss with prescribing clinician; monitor for bruising, prolonged bleeding, and dose adjustments. |
| Serrapeptase | Caution | Compound pairConfidence: theoretical | Additive antiplatelet/antithrombotic effect increases bleeding risk.Source pending | Discuss with prescribing clinician; monitor for bruising, prolonged bleeding, and dose adjustments. |
| Bromelain | Caution | Compound pairConfidence: theoretical | Additive antiplatelet/antithrombotic effect increases bleeding risk.Source pending | Discuss with prescribing clinician; monitor for bruising, prolonged bleeding, and dose adjustments. |
| Vitamin K1 | Caution | Compound pairConfidence: theoretical | Vitamin K reverses vitamin K antagonist activity and shifts INR.Source pending | Keep vitamin K intake consistent; do not start or stop supplementation without INR monitoring. |
| Vitamin K2 | Caution | Compound pairConfidence: theoretical | Vitamin K2 can shift INR on warfarin.Source pending | Discuss with prescribing clinician before adding K2. |
Frequently asked questions about Warfarin (Coumadin)
INR stands for International Normalized Ratio. It's a standardized measure of how long it takes a person's blood to clot. For individuals taking warfarin, maintaining the INR within a specific therapeutic range (typically 2.0 to 3.0, though it can vary based on the condition) is crucial to ensure the medication is effective enough to prevent clots but not so effective that it causes excessive bleeding. Regular INR testing, often weekly or bi-weekly initially, and then less frequently once stable, is essential. (Mayo Clinic)
Yes, diet can significantly affect warfarin's effectiveness, particularly foods high in vitamin K. Vitamin K plays a crucial role in blood clotting, and warfarin works by interfering with vitamin K's activity. Large fluctuations in vitamin K intake can alter warfarin's effect, making the blood either too thick (increasing clot risk) or too thin (increasing bleeding risk). It's generally recommended to maintain a consistent intake of vitamin K-containing foods rather than avoiding them entirely, and to discuss any significant dietary changes with your healthcare provider. (MedlinePlus)
If you miss a dose of warfarin, you should take it as soon as you remember on the same day. However, if it's already the next day, you should skip the missed dose and resume your regular dosing schedule. Do not take a double dose to make up for a missed one, as this can significantly increase your risk of bleeding. Always contact your healthcare provider or pharmacist for specific advice regarding missed doses. (FDA label)
The duration of warfarin therapy varies greatly depending on the underlying medical condition being treated. For some conditions, such as after certain surgeries or for a first DVT, treatment may last for a few months. For chronic conditions like atrial fibrillation or mechanical heart valves, warfarin therapy may be lifelong. Your healthcare provider will determine the appropriate duration based on your individual risk factors and the specific reason for treatment. (NIH)
Warfarin (Coumadin) is a medication, and interactions are possible with prescriptions, hormones, peptides and other supplements in the same routine. Because Warfarin (Coumadin) is usually taken evening, most avoidable conflicts come from what else lands in that same window. With a reported plasma half-life near 20 hours, separating doses can change the picture as much as removing one. Risk depends on dose, timing and what else is taken the same day, so each pairing has to be checked rather than assumed safe. The free checker at https://doseroutine.com/interaction-checker covers Warfarin (Coumadin) with no sign-up.
Combining a medication like Warfarin (Coumadin) with TRT is usually a question of labs rather than a blanket yes or no: the ester, injection interval and any aromatase inhibitor all change the answer. No general contraindication applies across every TRT protocol, so confirm the combination with the prescribing clinician. See the free TRT interaction reference: https://doseroutine.com/trt-supplement-interactions
Each peptide class carries its own profile against Warfarin (Coumadin): a healing peptide raises different questions than a GLP-1 agonist or a growth-hormone secretagogue. Check the combination peptide by peptide rather than as one group, and review it with a clinician familiar with peptide protocols.
With a plasma half-life near 20 hours, once-daily dosing is the usual pattern for Warfarin (Coumadin). It is typically taken evening. Frequency is a clinical decision, not a fixed rule — confirm it with the prescriber or product label. Comparison of apps that keep a schedule like this: https://doseroutine.com/best-dose-tracking-apps
For Warfarin (Coumadin) the useful record is the dose, the time it was actually taken, and what else was taken in the same window. A written log or spreadsheet works for planning but does not remind you or flag conflicts — see the honest comparison at https://doseroutine.com/vs/spreadsheet and the wider roundup at https://doseroutine.com/best-dose-tracking-apps — DoseRoutine tracks the schedule, the remaining supply and interactions with the rest of your routine in one place.
Which studies looked at Warfarin (Coumadin)?
Peer-reviewed research indexed in PubMed. Each entry links to the original record.
- 1.A Comprehensive Review of Potential Warfarin-Fruit Interactions(opens PubMed in a new tab)J Pharm Pract · 2015 · PMID 25112306 · https://pubmed.ncbi.nlm.nih.gov/25112306/
- 2.Clinical pharmacokinetics and pharmacodynamics of warfarin. Understanding the dose-effect relationship.(opens PubMed in a new tab)Clinical pharmacokinetics · 1986 · PMID 3542339 · https://pubmed.ncbi.nlm.nih.gov/3542339/
- 3.An algorithm for managing warfarin resistance(opens PubMed in a new tab)Cleve Clin J Med · 2009 · PMID 19952297 · https://pubmed.ncbi.nlm.nih.gov/19952297/
- 4.Warfarin versus low-molecular-weight heparin therapy in cancer patients(opens PubMed in a new tab)Oncologist · 2005 · PMID 15632254 · https://pubmed.ncbi.nlm.nih.gov/15632254/
- 5.Evidence-based adjustment of warfarin (Coumadin) doses(opens PubMed in a new tab)Am Fam Physician · 2005 · PMID 15926414 · https://pubmed.ncbi.nlm.nih.gov/15926414/
Sources cited on this page
Specific documents referenced by the numbered markers above. Each number matches the marker in the text.
- PubChem CID 16204922(opens in a new tab)National Center for Biotechnology Information · pubchem.ncbi.nlm.nih.gov/compound/16204922
Verify at
Publisher search links for Warfarin (Coumadin). These are places to check the information — they are not citations, so they are not numbered.
- Clinical practice guidelines (PubMed)(publisher search, opens in a new tab)National Library of Medicine · publisher search
- Cochrane Library(publisher search, opens in a new tab)Cochrane · publisher search
- DrugBank(publisher search, opens in a new tab)DrugBank Online · publisher search
- Examine.com(publisher search, opens in a new tab)Examine.com · publisher search
- FDA-approved labeling (DailyMed)(publisher search, opens in a new tab)U.S. Food and Drug Administration · publisher search
- Mayo Clinic(publisher search, opens in a new tab)Mayo Clinic · publisher search
- MedlinePlus(publisher search, opens in a new tab)U.S. National Library of Medicine · publisher search
- NIH Office of Dietary Supplements(publisher search, opens in a new tab)National Institutes of Health · publisher search
- PubMed literature search(publisher search, opens in a new tab)National Library of Medicine · publisher search
DoseRoutine compiles summaries from publicly available scientific and regulatory references. Always verify important decisions with a licensed clinician. How we source and review this information.
What is the short answer on Warfarin (Coumadin)?
Plain-text summary, safe to quote verbatim:
Warfarin, commonly known by its brand name Coumadin, is an anticoagulant medication. It functions as a vitamin K antagonist, meaning it reduces the ability of blood to clot. It is typically taken evening. The reported plasma half-life is about 20 hours, which shapes dosing frequency.
Source: DoseRoutine — https://doseroutine.com/library/warfarin-coumadin
Cite this page
Using this in an article, AI answer, or research note? Please attribute:
DoseRoutine. (2026). Warfarin (Coumadin) — Overview, Benefits & Side Effects. Retrieved from https://doseroutine.com/library/warfarin-coumadin
What compounds are similar to Warfarin (Coumadin)?
Others in the medication category or studied for the same goals.